Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
28.11.2023 - – Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life .
Newswire & Press Release / Ipsen Updates on E.U. Marketing Authorisation Application for Odevixibat in Alagille Syndrome - Pharma / BioTech / Nutrition - IPSEN Group newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.
Newswire & Press Release / Ipsen Updates on E.U. Marketing Authorisation Application for Odevixibat in Alagille Syndrome - Pharma / BioTech / Nutrition - IPSEN Group newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.